European Pharmaceutical Journal (Mar 2022)

Development and Validation of Bioanalytical Method for Determination of Nebivolol and Valsartan in Human Plasma by Using RP-HPLC

  • Kachave R. N.,
  • Mundhe A. G.

DOI
https://doi.org/10.2478/afpuc-2021-0019
Journal volume & issue
Vol. 68, no. 2
pp. 49 – 58

Abstract

Read online

Nebivolol and valsartan are used in the treatment of hypertension. So, this study was conducted for the purpose of determining bioavailability/bioequivalence of nebivolol and valsartan in human plasma.

Keywords